Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Cureus ; 16(2): e55089, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38558691

RESUMO

Background Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to prolonged symptoms post-recovery, commonly known as long-term coronavirus disease 2019 (COVID-19) or "long COVID." Neuropsychiatric consequences of long COVID include cognitive dysfunction and sleep disturbances, which significantly impair daily living. This study aimed to explore the impact of long COVID on cognitive performance and sleep quality in patients receiving outpatient care. Material and methods This study involved a random sample of 138 of 363 patients, corresponding to 38% of the cohort, who tested positive for SARS-CoV-2 via polymerase chain reaction (PCR) between May 2020 and April 2021. These unvaccinated, non-hospitalized individuals, predominantly exhibiting mild disease symptoms, were prospectively assessed 11 months post-positive PCR test. After informed consent, demographic data, memory, and concentration impairment levels were collected through interviews. Participants reporting cognitive symptoms underwent the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MOCA), and the Pittsburgh Sleep Quality Index. Statistical analyses were conducted, including Student's t-test, Chi-square, Fisher's test, Kruskal-Wallis test, and Pearson correlation coefficient, with a significance threshold set at p<0.05. Results Of the 138 participants, 76 (55.1%) were female and 62 (44.9%) were male. The mean age was 45.9 years (± 13.0), with an average educational attainment of 10.4 years (± 3.7). Roughly 50% of the patients reported significant memory and concentration issues (p<0.001). Thirty-three participants underwent detailed cognitive assessments, revealing a 2:1 female-to-male ratio and a significantly higher prevalence of depression in female participants. Cognitive deficits were diagnosed in five (15.2%) participants via the MMSE and in 26 (78.8%) via the MOCA test, with notable deficits in visuospatial/executive functions, language repeat, and deferred recall (p<0.001). A lower educational level was correlated with higher cognitive deficits (p=0.03). Conclusion The study findings reveal that cognitive impairments, as a consequence of COVID-19, can persist up to 11 months post-infection. The MOCA test proved more effective in diagnosing these deficits and requires adjustments based on educational background. Sleep parameters remained largely unaffected in this cohort, likely attributed to the mild nature of the initial symptoms and the outpatient management of the disease.

2.
Rev. méd. Chile ; 150(11): 1484-1492, nov. 2022. ilus, graf, tab
Artigo em Inglês | LILACS | ID: biblio-1442059

RESUMO

BACKGROUND: COVID-19 patients may experience Long-lasting symptoms from weeks to even months. AIM: To evaluate long-term cognitive impairment based on the severity of symptoms of COVID-19 infection in a primary health system setting. Material and Methods: From a database of 363 patients, 83 cases aged 47 ± 15 years, (58% females) were selected from June to August 2020. In patients who survived the virus, 24 infection-related symptoms were collected to create three severity clusters (mild, moderate, and severe). The follow-up time was at least seven months. Comparing the first two clusters with the severe cluster, the existence of brain fog and risk factors (obesity, hypertension, diabetes, chronic lung disease, and hypothyroidism) were analyzed. RESULTS: Thirty-one patients (37%) had persistent symptoms lasting up to 240 days. Fifty-one patients (61%) experienced brain fog. Concentration was affected by symptom severity (odds ratio [OR] 3.63, 95% confidence interval [CI] 1.26-10.46, p = 0.02). Short- or long-term memory loss was not affected. Moreover, symptom severity was related to brain fog (OR 3.16, 95% CI 1.05-9.51, p = 0.04). Patients with persistent symptoms had a concentration impairment associated with severity patterns (OR 24.3, 95% CI 1.73-340.11, p = 0.03). Conclusions: Brain fog is associated with symptom severity in COVID-19 survivors and lasts for more than eight months.


ANTECEDENTES: Los pacientes que han tenido COVID-19 pueden experimentar síntomas persistentes que duran semanas a meses. OBJETIVO: Evaluar el deterioro cognitivo a largo plazo en función de la severidad de los síntomas de la infección por COVID-19, en un escenario de sistema primario de salud. Material y Métodos: De una base de datos de 363 pacientes se seleccionaron 83 casos de 47 ± 15 años (58% mujeres), de junio-agosto de 2020. Se recopilaron 24 síntomas relacionados con la infección, creando tres grupos (leve, moderado y severo), en pacientes que padecieron y sobreviven al virus. El tiempo de seguimiento fue de al menos siete meses. La existencia de niebla cerebral y de factores de riesgo (obesidad, hipertensión, diabetes, enfermedad pulmonar crónica e hipotiroidismo) se comparó los dos grupos de severidad más bajos con el nivel superior. RESULTADOS: Treinta y un pacientes (37%) tuvieron síntomas prolongados con una duración de hasta 240 días. Cincuenta y un pacientes (61%) mostraron niebla cerebral. El deterioro de la concentración fue afectado por la severidad (Razón de riesgo (RR) = 3,63, Intervalos de confianza (IC) 95%: 1,26-10,46, p = 0,02). La pérdida de memoria a corto o largo plazo no fue afectada. El grupo con mayor severidad se asoció a niebla cerebral (RR = 3,16, IC95%: 1,05-9,51, p = 0,04). Los portadores de síntomas prolongados tuvieron una alteración de la concentración asociado a severidad (RR: 3,16, IC95%: 1,05-9,51, p= 0,04). Conclusiones: La niebla cerebral está relacionada con la severidad de los síntomas en supervivientes de COVID-19 permaneciendo por más de ocho meses.


Assuntos
Humanos , Masculino , Feminino , Diabetes Mellitus , COVID-19 , Hipertensão , Encéfalo , Fatores de Risco
3.
Rev Med Chil ; 150(11): 1484-1492, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37358174

RESUMO

BACKGROUND: COVID-19 patients may experience Long-lasting symptoms from weeks to even months. AIM: To evaluate long-term cognitive impairment based on the severity of symptoms of COVID-19 infection in a primary health system setting. MATERIAL AND METHODS: From a database of 363 patients, 83 cases aged 47 ± 15 years, (58% females) were selected from June to August 2020. In patients who survived the virus, 24 infection-related symptoms were collected to create three severity clusters (mild, moderate, and severe). The follow-up time was at least seven months. Comparing the first two clusters with the severe cluster, the existence of brain fog and risk factors (obesity, hypertension, diabetes, chronic lung disease, and hypothyroidism) were analyzed. RESULTS: Thirty-one patients (37%) had persistent symptoms lasting up to 240 days. Fifty-one patients (61%) experienced brain fog. Concentration was affected by symptom severity (odds ratio [OR] 3.63, 95% confidence interval [CI] 1.26-10.46, p = 0.02). Short- or long-term memory loss was not affected. Moreover, symptom severity was related to brain fog (OR 3.16, 95% CI 1.05-9.51, p = 0.04). Patients with persistent symptoms had a concentration impairment associated with severity patterns (OR 24.3, 95% CI 1.73-340.11, p = 0.03). CONCLUSIONS: Brain fog is associated with symptom severity in COVID-19 survivors and lasts for more than eight months.


Assuntos
COVID-19 , Diabetes Mellitus , Hipertensão , Feminino , Humanos , Masculino , Fatores de Risco , Encéfalo
4.
Comunidad salud ; 9(2): 1-8, dic. 2011. tab
Artigo em Espanhol | LILACS | ID: lil-690927

RESUMO

La presente investigación tuvo como objetivos compararla prevalencia de obesidad según Índice de Masa Corporal (IMC),Circunferencia de Cintura (CC) e Índice Cintura -Talla (ICT) y determinar los factores de riesgo para obesidad central por ICT. Fue diseñado un estudio de prevalencia, con una poblacion de 1298 estudiantes de Ingenieria Civil entre 18 y 24 años de edad de la Universidad Centro Occidental Lisandro Alvarado, 702 mujeres y 596 hombres. La selección de la muestra se basó en una prevalencia de obesidad central de 17%, nivel de confianza de 95% y un error de 3,6% para mujeres y 4,6% para hombres, para un tamaño de 259 mujeres y 180 hombres. Se determinaron IMC, CC e ICT. Se aplicó un cuestionario sobre antecedentes de obesidad familiar, hábitos dietéticos y sedentarismo. Los resultados reportaron 5,3% de obesos según IMC; 10% de obesidad central según CC y 41% según ICT, 37,8% mujeres y 45,6% hombres. En sujetos con antecedentes familiares de obesidad, 50,5% presentaron obesidad central mientras 37,8% sin estos antecedentes eran obesos (Razón de prevalencia = 1,33; IC95% = 1,06-1,68); 47,8% de sujetos sedentarios presentaron obesidad central respecto al 35,3% de sujetos sin sedentarismo (Razón de prevalencia = 1,35; IC95% = 1,08-1,69); 39% de los jóvenes con hábitos dietéticos inadecuados presentó obesidad central, 43% sin estos hábitos eran obesos (Razón de prevalencia = 0,90; IC95% = 0,72-1,13). Se concluye que la mayor prevalencia de obesidad central fue con el ICT y los factores de riesgo fueron antecedentes familiares de obesidad y sedentarismo. El ICT puede ser una herramienta más sensible que la CC para diagnosticar obesidad central en los jóvenes estudiado.


This research had, as objectives, to compare the obesity prevalence according to the Corporal Mass Index (CMI), Waist Circumference (WC) and Waist-Height Index (WHI) and to determine the risk factors for central obesity by WHI method. To determine antecedents of inherited obesity, dietetic habits and sedentariness, a questionnaire was applied. The estimated sample was based on a prevalence of central obesity of 17%, a level of 95% certainty and an error of 3.6% for female and 4.6% for male ones. Anthropometric measures CMI, WC and WHI were taken. Results from 702 women and 596 men aged 18 and 24 years, 259 women and 180 men were studied. 5.3% of obese subjects according to CMI, 10% central obesity according to WC and 41% according to WHI were found. A 37.8% of women and 45.6% of men displayed central obesity according to WHI. In subjects with an obesity family background, 50.5% displayed central obesity, unlike the subjects without family obesity (37.8%), (Reason of prevalence (RP) = 1,33; CI95% = 1,06-1,68). 47.8% of sedentary subjects displayed central obesity regarding to 35.3% of subjects without sedentariness (RP = 1,35; CI95% = 1,08-1,69). 39% of the young people with inadequate dietetic habits displayed central obesity, whereas 43% without these habits were obese (RP = 0,90; CI95% = 0,72-1,13). Conclusions. It was found that a greater prevalence of central obesity with the WHI and the risk factors were antecedents of family obesity and sedentariness. The WHI can be a tool more perceptible than the WC for diagnosing central obesity in this studied young people.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA